_id
6917299b3c536f8df2316d43
Ticker
VMTHF
Name
Venus Medtech (Hangzhou) Inc
Exchange
PINK
Address
No. 88, Jiangling Road, Hangzhou, China, 310051
Country
USA
Sector
Healthcare
Industry
Medical Devices
Currency
USD
Website
https://www.venusmedtech.com
Description
Venus Medtech (Hangzhou) Inc., together with its subsidiaries, engages in the research, development, manufacturing, and sale of bioprosthetic heart valves in Mainland China and internationally. The company's offers transcatheter aortic heart valve replacement products, such as VenusA-Valve, VenusA-Plus, VenusA-Pro, and VenusA-Deluxe; and VenusP-Valve, a transcatheter pulmonary valve system to treat the patients suffering with moderate to severe pulmonary regurgitation with or without right ventricular outflow tract stenosis. It also develops Venus-Vitae, a balloon-expandable dry-tissue product; Venus-PowerX, a self-expanding dry-tissue product; Cardiovalve, a transcatheter valve replacement system for the treatment of patients with mitral regurgitation and in pivotal clinical trial for the treatment of patients with tricuspid regurgitation; Liwen RF, a radiofrequency ablation system for the treatment of hypertrophic cardiomyopathy; and renal artery denervation ablation system for the treatment of hypertension. In addition, the company offers procedural accessories comprising catheter sheath product and balloon catheter. Venus Medtech (Hangzhou) Inc. was incorporated in 2009 and is headquartered in Hangzhou, the People's Republic of China.
Last Close
0.2681
Volume
-
Current Price
0.2681
Change
0
Last Updated
2026-01-08T12:22:39.488Z
Image
https://logo.clearbit.com/www.venusmedtech.com
Ipo Date
-
Market Cap
154703168
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
187137000
Cost Of Revenue
49149000
Gross Profit
137988000
Operating Expenses
275117000
Operating Income
-137129000
Interest Expense
7172000
Pretax Income
-138564000
Net Income
-134772000
Eps
-0.3077706941531513
Dividends Per Share
-
Shares Outstanding
441010235
Income Tax Expense
3792000
EBITDA
-122182000
Operating Margin
-73.27733158060671
Total Other Income Expense Net
-1435000
Cash
278995000
Short Term Investments
14311000
Receivables
137529000
Inventories
104166000
Total Current Assets
732622000
Property Plant Equipment
501441000
Total Assets
3120015000
Payables
22417000
Short Term Debt
201864000
Long Term Debt
258439000
Total Liabilities
1053748000
Equity
2066266999
Bs_currency_symbol
CNY
Depreciation
14947000
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
Cf_currency_symbol
-
PE
-
PB
0.05681758675191424
ROE
-6.522487174466073
ROA
-4.31959461733357
FCF
-
Fcf Percent
-
Piotroski FScore
0
Health Score
37
Deep Value Investing Score
6
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
2
Growth Investing Score
1
Momentum Investing Score
2
Net Net Investing Score
2.5
Quality Investing Score
2
Value Investing Score
4.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
187137000
Quarters > 0 > income Statement > cost Of Revenue
49149000
Quarters > 0 > income Statement > gross Profit
137988000
Quarters > 0 > income Statement > operating Expenses
275117000
Quarters > 0 > income Statement > operating Income
-137129000
Quarters > 0 > income Statement > interest Expense
7172000
Quarters > 0 > income Statement > pretax Income
-138564000
Quarters > 0 > income Statement > net Income
-134772000
Quarters > 0 > income Statement > eps
-0.3077706941531513
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
437897443
Quarters > 0 > income Statement > income Tax Expense
3792000
Quarters > 0 > income Statement > EBITDA
-122182000
Quarters > 0 > income Statement > operating Margin
-73.27733158060671
Quarters > 0 > income Statement > total Other Income Expense Net
-1435000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
278995000
Quarters > 0 > balance Sheet > short Term Investments
14311000
Quarters > 0 > balance Sheet > receivables
137529000
Quarters > 0 > balance Sheet > inventories
104166000
Quarters > 0 > balance Sheet > total Current Assets
732622000
Quarters > 0 > balance Sheet > property Plant Equipment
501441000
Quarters > 0 > balance Sheet > total Assets
3120015000
Quarters > 0 > balance Sheet > payables
22417000
Quarters > 0 > balance Sheet > short Term Debt
201864000
Quarters > 0 > balance Sheet > long Term Debt
258439000
Quarters > 0 > balance Sheet > total Liabilities
1053748000
Quarters > 0 > balance Sheet > equity
2066266999
Quarters > 0 > balance Sheet > currency_symbol
CNY
Quarters > 0 > cash Flow > net Income
-134772000
Quarters > 0 > cash Flow > depreciation
14947000
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.3077706941531513
Quarters > 0 > ratios > PB
0.05681758675191424
Quarters > 0 > ratios > ROE
-6.522487174466073
Quarters > 0 > ratios > ROA
-4.31959461733357
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
37
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
240113000
Quarters > 1 > income Statement > cost Of Revenue
54127000
Quarters > 1 > income Statement > gross Profit
185986000
Quarters > 1 > income Statement > operating Expenses
326672000
Quarters > 1 > income Statement > operating Income
-140686000
Quarters > 1 > income Statement > interest Expense
16647000
Quarters > 1 > income Statement > pretax Income
-536644000
Quarters > 1 > income Statement > net Income
-507820000
Quarters > 1 > income Statement > eps
-1.159677929427873
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
437897443
Quarters > 1 > income Statement > income Tax Expense
-28096000
Quarters > 1 > income Statement > EBITDA
-450207000
Quarters > 1 > income Statement > operating Margin
-58.591579797845185
Quarters > 1 > income Statement > total Other Income Expense Net
-395958000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
298036000
Quarters > 1 > balance Sheet > short Term Investments
7666000
Quarters > 1 > balance Sheet > receivables
331115000
Quarters > 1 > balance Sheet > inventories
98061000
Quarters > 1 > balance Sheet > total Current Assets
802480000
Quarters > 1 > balance Sheet > property Plant Equipment
523899000
Quarters > 1 > balance Sheet > total Assets
3249770000
Quarters > 1 > balance Sheet > payables
30229000
Quarters > 1 > balance Sheet > short Term Debt
56109000
Quarters > 1 > balance Sheet > long Term Debt
265455000
Quarters > 1 > balance Sheet > total Liabilities
1038671000
Quarters > 1 > balance Sheet > equity
2211099000
Quarters > 1 > balance Sheet > currency_symbol
CNY
Quarters > 1 > cash Flow > net Income
-534226000
Quarters > 1 > cash Flow > depreciation
52619000
Quarters > 1 > cash Flow > change In Working Capital
55800000
Quarters > 1 > cash Flow > cash From Operations
-58509000
Quarters > 1 > cash Flow > capital Expenditures
2002000
Quarters > 1 > cash Flow > cash From Investing
17228000
Quarters > 1 > cash Flow > cash From Financing
-149365000
Quarters > 1 > cash Flow > net Change In Cash
442312500
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-1.159677929427873
Quarters > 1 > ratios > PB
0.053095905912987164
Quarters > 1 > ratios > ROE
-22.966859466717683
Quarters > 1 > ratios > ROA
-15.62633663305403
Quarters > 1 > ratios > FCF
-60511000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.25201051171739974
Quarters > 1 > health Score
34
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
230720000
Quarters > 2 > income Statement > cost Of Revenue
48960000
Quarters > 2 > income Statement > gross Profit
181760000
Quarters > 2 > income Statement > operating Expenses
387671000
Quarters > 2 > income Statement > operating Income
-205911000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-213581000
Quarters > 2 > income Statement > net Income
-206487000
Quarters > 2 > income Statement > eps
-0.4715419176357237
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
437897443
Quarters > 2 > income Statement > income Tax Expense
-4756000
Quarters > 2 > income Statement > EBITDA
-162750000
Quarters > 2 > income Statement > operating Margin
-89.24713938973647
Quarters > 2 > income Statement > total Other Income Expense Net
-7670000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
485843000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
273100000
Quarters > 2 > balance Sheet > inventories
123683000
Quarters > 2 > balance Sheet > total Current Assets
1095145000
Quarters > 2 > balance Sheet > property Plant Equipment
702601000
Quarters > 2 > balance Sheet > total Assets
3896762000
Quarters > 2 > balance Sheet > payables
40140000
Quarters > 2 > balance Sheet > short Term Debt
164582000
Quarters > 2 > balance Sheet > long Term Debt
265453000
Quarters > 2 > balance Sheet > total Liabilities
1174665000
Quarters > 2 > balance Sheet > equity
2725525000
Quarters > 2 > balance Sheet > currency_symbol
CNY
Quarters > 2 > cash Flow > net Income
-206487000
Quarters > 2 > cash Flow > depreciation
58490000
Quarters > 2 > cash Flow > change In Working Capital
253790998
Quarters > 2 > cash Flow > cash From Operations
82248000
Quarters > 2 > cash Flow > capital Expenditures
43558000
Quarters > 2 > cash Flow > cash From Investing
-37126000
Quarters > 2 > cash Flow > cash From Financing
-337974000
Quarters > 2 > cash Flow > net Change In Cash
-144276500
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.4715419176357237
Quarters > 2 > ratios > PB
0.043074381804716524
Quarters > 2 > ratios > ROE
-7.5760449821594005
Quarters > 2 > ratios > ROA
-5.298937938729643
Quarters > 2 > ratios > FCF
38690000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
0.16769244105409153
Quarters > 2 > health Score
49
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
115360000
Quarters > 3 > income Statement > cost Of Revenue
24480000
Quarters > 3 > income Statement > gross Profit
90880000
Quarters > 3 > income Statement > operating Expenses
193835500
Quarters > 3 > income Statement > operating Income
-102955500
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-106790500
Quarters > 3 > income Statement > net Income
-103243500
Quarters > 3 > income Statement > eps
-0.23577095881786184
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
437897443
Quarters > 3 > income Statement > income Tax Expense
2378000
Quarters > 3 > income Statement > EBITDA
-81375000
Quarters > 3 > income Statement > operating Margin
-89.24713938973647
Quarters > 3 > income Statement > total Other Income Expense Net
-3835000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
485843000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
273100000
Quarters > 3 > balance Sheet > inventories
123683000
Quarters > 3 > balance Sheet > total Current Assets
1095145000
Quarters > 3 > balance Sheet > property Plant Equipment
702601000
Quarters > 3 > balance Sheet > total Assets
3896762000
Quarters > 3 > balance Sheet > payables
40140000
Quarters > 3 > balance Sheet > short Term Debt
164582000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1174665000
Quarters > 3 > balance Sheet > equity
2725525000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-103243500
Quarters > 3 > cash Flow > depreciation
29245000
Quarters > 3 > cash Flow > change In Working Capital
126895499
Quarters > 3 > cash Flow > cash From Operations
41124000
Quarters > 3 > cash Flow > capital Expenditures
21779000
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-168987000
Quarters > 3 > cash Flow > net Change In Cash
-144276500
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.23577095881786184
Quarters > 3 > ratios > PB
0.043074381804716524
Quarters > 3 > ratios > ROE
-3.7880224910797002
Quarters > 3 > ratios > ROA
-2.6494689693648215
Quarters > 3 > ratios > FCF
19345000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
0.16769244105409153
Quarters > 3 > health Score
49
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
470833000
Annuals > 0 > income Statement > cost Of Revenue
103087000
Annuals > 0 > income Statement > gross Profit
367746000
Annuals > 0 > income Statement > operating Expenses
714343000
Annuals > 0 > income Statement > operating Income
-346597000
Annuals > 0 > income Statement > interest Expense
16647000
Annuals > 0 > income Statement > pretax Income
-740713000
Annuals > 0 > income Statement > net Income
-714307000
Annuals > 0 > income Statement > eps
-1.6312198470635966
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
437897443
Annuals > 0 > income Statement > income Tax Expense
-23340000
Annuals > 0 > income Statement > EBITDA
-612957000
Annuals > 0 > income Statement > operating Margin
-73.61357423969858
Annuals > 0 > income Statement > total Other Income Expense Net
-394116000
Annuals > 0 > income Statement > currency_symbol
CNY
Annuals > 0 > balance Sheet > cash
298036000
Annuals > 0 > balance Sheet > short Term Investments
7666000
Annuals > 0 > balance Sheet > receivables
331115000
Annuals > 0 > balance Sheet > inventories
98061000
Annuals > 0 > balance Sheet > total Current Assets
802480000
Annuals > 0 > balance Sheet > property Plant Equipment
523899000
Annuals > 0 > balance Sheet > total Assets
3249770000
Annuals > 0 > balance Sheet > payables
30229000
Annuals > 0 > balance Sheet > short Term Debt
56109000
Annuals > 0 > balance Sheet > long Term Debt
265455000
Annuals > 0 > balance Sheet > total Liabilities
1038671000
Annuals > 0 > balance Sheet > equity
2211099000
Annuals > 0 > balance Sheet > currency_symbol
CNY
Annuals > 0 > cash Flow > net Income
-740713000
Annuals > 0 > cash Flow > depreciation
111109000
Annuals > 0 > cash Flow > change In Working Capital
309591000
Annuals > 0 > cash Flow > cash From Operations
23739000
Annuals > 0 > cash Flow > capital Expenditures
41556000
Annuals > 0 > cash Flow > cash From Investing
-19898000
Annuals > 0 > cash Flow > cash From Financing
-487339000
Annuals > 0 > cash Flow > net Change In Cash
-476360000
Annuals > 0 > cash Flow > currency_symbol
CNY
Annuals > 0 > ratios > PE
-1.6312198470635966
Annuals > 0 > ratios > PB
0.053095905912987164
Annuals > 0 > ratios > ROE
-32.305518658368534
Annuals > 0 > ratios > ROA
-21.980232447219343
Annuals > 0 > ratios > FCF
-17817000
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
-0.03784144271960547
Annuals > 0 > health Score
35
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
491373000
Annuals > 1 > income Statement > cost Of Revenue
102168000
Annuals > 1 > income Statement > gross Profit
389205000
Annuals > 1 > income Statement > operating Expenses
977749999
Annuals > 1 > income Statement > operating Income
-589973000
Annuals > 1 > income Statement > interest Expense
62716000
Annuals > 1 > income Statement > pretax Income
-735340000
Annuals > 1 > income Statement > net Income
-703754000
Annuals > 1 > income Statement > eps
-1.6071205969567628
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
437897443
Annuals > 1 > income Statement > income Tax Expense
-6284000
Annuals > 1 > income Statement > EBITDA
-547837000
Annuals > 1 > income Statement > operating Margin
-120.06622260482362
Annuals > 1 > income Statement > total Other Income Expense Net
-146795000
Annuals > 1 > income Statement > currency_symbol
CNY
Annuals > 1 > balance Sheet > cash
774396000
Annuals > 1 > balance Sheet > short Term Investments
7240000
Annuals > 1 > balance Sheet > receivables
290607000
Annuals > 1 > balance Sheet > inventories
112942000
Annuals > 1 > balance Sheet > total Current Assets
1608067000
Annuals > 1 > balance Sheet > property Plant Equipment
693468000
Annuals > 1 > balance Sheet > total Assets
4413714000
Annuals > 1 > balance Sheet > payables
33855000
Annuals > 1 > balance Sheet > short Term Debt
494700000
Annuals > 1 > balance Sheet > long Term Debt
248929000
Annuals > 1 > balance Sheet > total Liabilities
1494368000
Annuals > 1 > balance Sheet > equity
2920648000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-703754000
Annuals > 1 > cash Flow > depreciation
124787000
Annuals > 1 > cash Flow > change In Working Capital
-117430000
Annuals > 1 > cash Flow > cash From Operations
-610019000
Annuals > 1 > cash Flow > capital Expenditures
262908000
Annuals > 1 > cash Flow > cash From Investing
-346859000
Annuals > 1 > cash Flow > cash From Financing
-173986000
Annuals > 1 > cash Flow > net Change In Cash
-1105035000
Annuals > 1 > cash Flow > currency_symbol
CNY
Annuals > 1 > ratios > PE
-1.6071205969567628
Annuals > 1 > ratios > PB
0.04019666336658852
Annuals > 1 > ratios > ROE
-24.095817092645195
Annuals > 1 > ratios > ROA
-15.944712321641138
Annuals > 1 > ratios > FCF
-872927000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-1.7765058316187499
Annuals > 1 > health Score
29
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
406461000
Annuals > 2 > income Statement > cost Of Revenue
92463000
Annuals > 2 > income Statement > gross Profit
313998000
Annuals > 2 > income Statement > operating Expenses
948883000
Annuals > 2 > income Statement > operating Income
-650214000
Annuals > 2 > income Statement > interest Expense
44623000
Annuals > 2 > income Statement > pretax Income
-1156344000
Annuals > 2 > income Statement > net Income
-1057699000
Annuals > 2 > income Statement > eps
-2.415403462403867
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
437897443
Annuals > 2 > income Statement > income Tax Expense
-34302000
Annuals > 2 > income Statement > EBITDA
-999369000
Annuals > 2 > income Statement > operating Margin
-159.96959117848945
Annuals > 2 > income Statement > total Other Income Expense Net
-506130000
Annuals > 2 > income Statement > currency_symbol
CNY
Annuals > 2 > balance Sheet > cash
1879431000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
303388000
Annuals > 2 > balance Sheet > inventories
104396000
Annuals > 2 > balance Sheet > total Current Assets
2468970000
Annuals > 2 > balance Sheet > property Plant Equipment
472023000
Annuals > 2 > balance Sheet > total Assets
5282835000
Annuals > 2 > balance Sheet > payables
9126000
Annuals > 2 > balance Sheet > short Term Debt
246060000
Annuals > 2 > balance Sheet > long Term Debt
573379000
Annuals > 2 > balance Sheet > total Liabilities
1651524000
Annuals > 2 > balance Sheet > equity
3607864000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-857766000
Annuals > 2 > cash Flow > depreciation
112352000
Annuals > 2 > cash Flow > change In Working Capital
-129783000
Annuals > 2 > cash Flow > cash From Operations
-729459000
Annuals > 2 > cash Flow > capital Expenditures
178774000
Annuals > 2 > cash Flow > cash From Investing
-1072266000
Annuals > 2 > cash Flow > cash From Financing
635137000
Annuals > 2 > cash Flow > net Change In Cash
-1075781000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-2.415403462403867
Annuals > 2 > ratios > PB
0.03254011361523051
Annuals > 2 > ratios > ROE
-29.31648753944162
Annuals > 2 > ratios > ROA
-20.021427888624196
Annuals > 2 > ratios > FCF
-908233000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-2.234489901860203
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
415862000
Annuals > 3 > income Statement > cost Of Revenue
91518000
Annuals > 3 > income Statement > gross Profit
324344000
Annuals > 3 > income Statement > operating Expenses
596301000
Annuals > 3 > income Statement > operating Income
-278644000
Annuals > 3 > income Statement > interest Expense
1905000
Annuals > 3 > income Statement > pretax Income
-377555000
Annuals > 3 > income Statement > net Income
-373636000
Annuals > 3 > income Statement > eps
-0.851927908597928
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
438577016
Annuals > 3 > income Statement > income Tax Expense
-6161000
Annuals > 3 > income Statement > EBITDA
-324029000
Annuals > 3 > income Statement > operating Margin
-67.00395804377413
Annuals > 3 > income Statement > total Other Income Expense Net
-98911000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
2955212000
Annuals > 3 > balance Sheet > short Term Investments
-4313000
Annuals > 3 > balance Sheet > receivables
302096000
Annuals > 3 > balance Sheet > inventories
90519000
Annuals > 3 > balance Sheet > total Current Assets
3439622000
Annuals > 3 > balance Sheet > property Plant Equipment
261546000
Annuals > 3 > balance Sheet > total Assets
5109457000
Annuals > 3 > balance Sheet > payables
8751000
Annuals > 3 > balance Sheet > short Term Debt
22627000
Annuals > 3 > balance Sheet > long Term Debt
0
Annuals > 3 > balance Sheet > total Liabilities
477613000
Annuals > 3 > balance Sheet > equity
4545630000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-373636000
Annuals > 3 > cash Flow > depreciation
51621000
Annuals > 3 > cash Flow > change In Working Capital
-150591000
Annuals > 3 > cash Flow > cash From Operations
-456917000
Annuals > 3 > cash Flow > capital Expenditures
145164000
Annuals > 3 > cash Flow > cash From Investing
-653038000
Annuals > 3 > cash Flow > cash From Financing
1391401000
Annuals > 3 > cash Flow > net Change In Cash
247042000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.851927908597928
Annuals > 3 > ratios > PB
0.025867151085680093
Annuals > 3 > ratios > ROE
-8.219674720555787
Annuals > 3 > ratios > ROA
-7.312636156836236
Annuals > 3 > ratios > FCF
-602081000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-1.4477903727678894
Annuals > 3 > health Score
34
Valuation > metrics > PE
-0.3077706941531513
Valuation > metrics > PB
0.05681758675191424
Valuation > final Score
70
Valuation > verdict
94.3% Undervalued
Profitability > metrics > ROE
-6.522487174466073
Profitability > metrics > ROA
-18.39584396864959
Profitability > metrics > Net Margin
-0.7201782651212748
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.5099766876739438
Risk > metrics > Interest Coverage
-19.120050195203568
Risk > final Score
-28
Risk > verdict
High
Liquidity > metrics > Current Ratio
3.2665361756011433
Liquidity > metrics > Quick Ratio
2.802092018494656
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
26
Prev Risks > 1
44
Prev Risks > 2
44
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:47:21.949Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-26
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Venus Medtech (Hangzhou) Inc., together with its subsidiaries, engages in the research, development, manufacturing, and sale of bioprosthetic heart valves in Mainland China and internationally. The company's offers transcatheter aortic heart valve replacement products, such as VenusA-Valve, VenusA-Plus, VenusA-Pro, and VenusA-Deluxe; and VenusP-Valve, a transcatheter pulmonary valve system to treat the patients suffering with moderate to severe pulmonary regurgitation with or without right ventricular outflow tract stenosis. It also develops Venus-Vitae, a balloon-expandable dry-tissue product; Venus-PowerX, a self-expanding dry-tissue product; Cardiovalve, a transcatheter valve replacement system for the treatment of patients with mitral regurgitation and in pivotal clinical trial for the treatment of patients with tricuspid regurgitation; Liwen RF, a radiofrequency ablation system for the treatment of hypertrophic cardiomyopathy; and renal artery denervation ablation system for the treatment of hypertension. In addition, the company offers procedural accessories comprising catheter sheath product and balloon catheter. Venus Medtech (Hangzhou) Inc. was incorporated in 2009 and is headquartered in Hangzhou, the People's Republic of China.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Venus Medtech (Hangzhou) Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
—
EPS Actual
—
EPS Estimate
—
EPS Difference
—
Surprise Percent
undefined%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.